Search research articles
Contact Us
Filters
Showing results (1481-1490 of 1,853) with videos related to
Page
of 186
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
Tilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
The Journal of Infectious Diseases
|
November 9, 2022
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study
Daniel J Stieh, Dan H Barouch, Christy Comeaux, et al.
Science Advances
|
February 1, 2021
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
Avani Yeola, Shruthi Subramanian, Rema A Oliver, et al.
The Lancet. Infectious Diseases
|
August 14, 2010
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K Kumarasamy, Mark A Toleman, Timothy R Walsh, et al.
Plos One
|
August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Yehuda Z Cohen, Allison L Butler, Katrina Millard, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
The Lancet. Infectious Diseases
|
June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study
Yang Wang, Chunyan Xu, Rong Zhang, et al.
The Journal of Infectious Diseases
|
October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083
Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Nature Microbiology
|
March 30, 2021
Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries
Kirsty Sands, Maria J Carvalho, Edward Portal, et al.
Ebiomedicine
|
September 22, 2023
Risk of COVID-19 after natural infection or vaccination
Anne-Marie Rick, Matthew B Laurens, Ying Huang, et al.
Page
of 186
Search research articles
Search
Showing results (1481-1490 of 1,853) with videos related to
Sort By:
Page
of 186
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
Tilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
The Journal of Infectious Diseases
|
November 9, 2022
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study
Daniel J Stieh, Dan H Barouch, Christy Comeaux, et al.
Science Advances
|
February 1, 2021
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
Avani Yeola, Shruthi Subramanian, Rema A Oliver, et al.
The Lancet. Infectious Diseases
|
August 14, 2010
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K Kumarasamy, Mark A Toleman, Timothy R Walsh, et al.
Plos One
|
August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Yehuda Z Cohen, Allison L Butler, Katrina Millard, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
The Lancet. Infectious Diseases
|
June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study
Yang Wang, Chunyan Xu, Rong Zhang, et al.
The Journal of Infectious Diseases
|
October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083
Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Nature Microbiology
|
March 30, 2021
Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries
Kirsty Sands, Maria J Carvalho, Edward Portal, et al.
Ebiomedicine
|
September 22, 2023
Risk of COVID-19 after natural infection or vaccination
Anne-Marie Rick, Matthew B Laurens, Ying Huang, et al.
Page
of 186